3.1.4 Compound bronchodilator preparations
Beclometasone + Formoterol + Glycopyrronium bromide
Trimbow 87micrograms/dose / 5micrograms/dose / 9micrograms/dose inhaler
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Chronic Obstructive Pulmonary Disease (COPD) |
Trimbow NEXThaler 88micrograms/dose / 5micrograms/dose / 9micrograms/dose dry powder inhaler
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Chronic Obstructive Pulmonary Disease (COPD) |
Glycopyrronium bromide + Formoterol
Bevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhaler
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Chronic Obstructive Pulmonary Disease (COPD) |
Tiotropium + Olodaterol
Spiolto Respimat 2.5micrograms/dose / 2.5micrograms/dose inhalation solution cartridge with device
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Chronic Obstructive Pulmonary Disease (COPD) |
Spiolto Respimat 2.5micrograms/dose / 2.5micrograms/dose inhalation solution refill cartridge
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Chronic Obstructive Pulmonary Disease (COPD) |
Umeclidinium bromide + Vilanterol
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Chronic Obstructive Pulmonary Disease (COPD) |